MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
304.92
+0.43
+0.14%
After Hours: 304.93 +0.01 +0.00% 16:49 11/30 EST
OPEN
304.10
PREV CLOSE
304.49
HIGH
306.13
LOW
300.31
VOLUME
213.50K
TURNOVER
0
52 WEEK HIGH
509.62
52 WEEK LOW
261.59
MARKET CAP
8.89B
P/E (TTM)
-54.8546
1D
5D
1M
3M
1Y
5Y
SPY ETF Update, 11/30/2023
TipRanks · 1d ago
Bio Rad Labs Inc: Statement of changes in beneficial ownership of securities
Press release · 3d ago
Bio Rad Labs Inc: Report of proposed sale of securities
Press release · 3d ago
SPY ETF Update, 11/28/2023
TipRanks · 3d ago
Weekly Report: what happened at BIO last week (1120-1124)?
Weekly Report · 4d ago
Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
Several s&p 500 stocks are trading at significant discounts compared to their average year-ahead price targets set by analysts. Discounts can arise due to market volatility, economic downturns or industry-specific issues. 10 stocks are currently trading at discounts of over 40% compared to analysts' average price targets.
Benzinga · 11/24 18:34
SPY ETF Update, 11/24/2023
Spy is up 0.86% in the past 5 days and has risen nearly 21% year-to-date. The spdr s&p 500 etf trust is a moderate buy, according to tipranks. The street's average price target of $506.46 implies an upside of 11.30%. Spy's five holdings have the highest upside potential.
TipRanks · 11/24 10:53
SPY ETF Update, 11/23/2023  
TipRanks · 11/23 08:18
More
About BIO
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.

Webull offers Bio Rad Laboratories Inc stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.